1. Hims & Hers Stock Momentum Tied to RFK Jr.'s Push for Looser Peptide Regulations
The telehealth and wellness platform Hims & Hers is positioned for a potential market surge, with its stock trajectory now directly linked to a high-profile political campaign. The catalyst is independent presidential candidate Robert F. Kennedy Jr.'s public advocacy for deregulating peptide therapies, a core product c...